Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus and MMF for GvHD Prophylaxis in HSCT
NCT01220297Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Aug 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sirolimus and mycophenolate mofetil in graft-versus-host disease (GVHD), sponsored by Stanford University. Started Aug 2006; status: terminated.
02
Drugs
sirolimusmycophenolate mofetil
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01220297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01220297.